Dialysis Centers Pay $2 Million to Settle Relief Claims
Texas operators must ensure accurate financial reporting to avoid False Claims Act liability when accessing federal aid.
Updated on Oct. 27, 2026 in Healthcare

Live Poll
Do you trust that federal COVID-19 pandemic relief programs were managed with adequate oversight?
Six Texas-based dialysis centers have agreed to pay $2 million to settle allegations of submitting false claims for pandemic relief funds. The settlement addresses claims that the centers improperly obtained Provider Relief Fund payments after they had already ceased operations or sold their businesses.
Why it matters
Operators in the healthcare sector must ensure strict compliance with federal reporting requirements regarding pandemic-era financial aid. Mischaracterizing business status or revenue when seeking government assistance can trigger significant False Claims Act liabilities.
The $2 million settlement resolves allegations of improper claims filed with the Health Resources and Services Administration. This agreement involves six dialysis centers that had reportedly sold their businesses or closed before receiving the federal funding.
The players
Sankar Nephrology Group
A medical provider group acting as the guarantor for the settlement payment involving its former dialysis centers.
Health Resources and Services Administration
The federal agency tasked with administering the Provider Relief Fund that monitored the reported revenue of healthcare providers.
The details
The allegations stem from the reporting of zero revenue to the Health Resources and Services Administration while attempting to access the Provider Relief Fund created by the CARES Act. The government contends that the dialysis centers mischaracterized business closures as active pandemic-related financial impacts to obtain grants they were not entitled to receive. Sankar Nephrology Group will act as a guarantor for the $2 million payment to resolve the charges.
Timeline
March 29, 2020: Congress enacted the CARES Act.
October 27, 2026: The $2 million settlement was announced.
Market Landscape
This settlement follows a consistent pattern of federal enforcement actions taken against healthcare entities regarding the misuse of CARES Act Provider Relief Fund disbursements. It underscores the ongoing federal scrutiny of how providers reported revenue and business status during the pandemic.
Healthcare operators should review their historical pandemic relief applications to ensure all revenue and operational status reports were accurate. Those facing similar inquiries should consult with legal counsel regarding the potential for False Claims Act litigation.
The takeaway
The case highlights the importance of maintaining precise records of business operations when applying for federal aid, especially during periods of transition or closure. Healthcare owners should keep a detailed audit trail of all financial reporting submissions to demonstrate compliance with federal oversight requirements.
Further reading
For broader trends in industry regulation, see Healthcare.
Source note: This article includes information reported by The United States Department of Justice.
Live Poll
Do you trust that federal COVID-19 pandemic relief programs were managed with adequate oversight?




